Rafael Luque‐Márquez

Author

Instituto de Biomedicina de Sevilla ORCID

Also Known As

José López-Haldón, R Luque-Márquez, R. Luque-Márquez, R. Luque‐Marquez, Rafael Luque Márquez, Rafael Luque-Marquez, Rafael Luque-Márquez, Rafael Luque‐Márquez

Publications

600

Citations

H-Index

Concepts

All Affiliations

Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío Hospital Universitario Virgen Macarena Universidad de Sevilla Centro de Investigación Biomédica en Red

About

Rafael Luque‐Márquez is an author at Instituto de Biomedicina de Sevilla specializing in medicine, clinical microbiology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	48
2	Microbiology	1	1	26
3	Pharmacology	1	1	22
4	Antibiotics	1	1	26
5	Clinical Microbiology	1	1	26

Rafael Luque‐Márquez

Publications

344

Citations

H-Index

Page 1

	Year	Citations
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection Alberto Pérez‐Gómez, Joana Vitallé, Carmen Gasca‐Capote, Cellular and Molecular Immunology	2021	117
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome Sonsoles Salto‐Alejandre, Judith Berastegui‐Cabrera, Pedro Camacho‐Martínez, Scientific Reports	2021	31
Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa Jesus Cotrina Luqué, María Victoria Gil-Navarro, Héctor Acosta-García, International Journal of Clinical Pharmacy Antimicrobial SusceptibilityAntibioticsHealthcare-associated InfectionAntimicrobial ChemotherapyMicrobiology	2015	26
Outpatient parenteral antimicrobial therapy in <i>Enterococcus faecalis</i> infective endocarditis María-Victoria Gil-Navarro, Luis Eduardo López-Cortés, Rafael Luque‐Márquez, Journal of Clinical Pharmacy and Therapeutics	2017	24
Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy Laura Herrera‐Hidalgo, Luis Eduardo López-Cortés, Rafael Luque‐Márquez, Antimicrobial Agents and Chemotherapy	2020	22
Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application Laura Herrera‐Hidalgo, María Victoria Gil-Navarro, Sujan Dilly Penchala, Journal of Pharmaceutical and Biomedical Analysis Therapeutic Drug MonitoringMedicineSimple Lc–ms/ms MethodDrug MonitoringPharmacotherapy	2020	22
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT Laura Herrera‐Hidalgo, José Manuel Lomas-Cabezas, Luis Eduardo López-Cortés, Journal of Clinical Medicine	2021	20
Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs? Laura Herrera‐Hidalgo, Arístides de Alarcón, Luis Eduardo López-Cortés, Antimicrobial Agents and Chemotherapy	2020	13
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy Beatriz Fernández-Rubio, Laura Herrera‐Hidalgo, Arístides de Alarcón, Pharmaceutics	2023	13
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients María Victoria Gil-Navarro, Rafael Luque‐Márquez, Nerea Báez‐Gutiérrez, Enfermedades Infecciosas y Microbiología Clínica	2020	12

Page 1